Natural bacteria are interesting subjects for cancer treatments owing to their unique
autonomy‐driven and hypoxic target properties. Genetically modified bacteria (such as …

Targeted therapy and immunotherapy have brought hopes for precision cancer treatment.
However, complex physiological barriers and tumor immunosuppression result in poor …

Rapid advances in synthetic biology are driving the development of genetically engineered
microbes as therapeutic agents for a multitude of human diseases, including cancer. The …

There is growing interest in the role of microorganisms in human health and disease, with
evidence showing that new types of biotherapy using engineered bacterial therapeutics …

Enterobacterales represent the largest group of bacterial pathogens in humans and are
responsible for severe, deep-seated infections, often resulting in sepsis or death. They are …

Recent advances in molecular engineering and synthetic biology provide biomolecular and
cell-based therapies with a high degree of molecular specificity, but limited spatiotemporal …

By leveraging the ability of bacteria to express therapeutic protein cytolysin A (ClyA) through
plasmid transformation, a thermally‐activated biohybrid (TAB@ Au) is constructed by …

Photoacoustic (PA) imaging offers promise for biomedical applications due to its ability to
image deep within biological tissues while providing detailed molecular information; …

Cancer has been regarded as the leading cause of deaths worldwide. Although
conventional therapies have been applied for fighting against the cancer, the poor oxygen …

It is an active research area in the development of engineered bacteria to address the
bottleneck issue of hypoxic tumors, which otherwisely possess resistance to …